Effectiveness of high trough levels of cyclosporine for 5 months in a case of steroid-dependent nephrotic syndrome with severe steroid toxicity

被引:5
作者
Kano, K
Yamada, Y
Shiraiwa, T
Shimizu, A
Nishikura, K
Arisaka, O
Tomita, S
Ueda, Y
机构
[1] Dokkyo Univ, Sch Med, Dept Pediat, Shimotsuga, Tochigi 3210293, Japan
[2] Dokkyo Univ, Sch Med, Dept Surg & Mol Pathol, Shimotsuga, Tochigi 3210293, Japan
[3] Dokkyo Univ, Sch Med, Dept Pathol, Koshigaya Hosp, Shimotsuga, Tochigi 3210293, Japan
关键词
bone fracture; child; cyclosporine; epidural lipomatosis; nephrotic syndrome; prednisolone;
D O I
10.1111/j.1440-1797.2004.00341.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoid treatment for steroid-dependent nephrotic syndrome (NS) is associated with severe adverse effects, such as bone fractures and epidural lipomatosis. Furthermore, a high trough level of cyclosporine (CsA) over an extended period of time is known to induce CsA nephropathy. We present a girl with steroid-dependent NS and steroid-induced vertebral compression fractures and epidural lipomatosis who was treated with a high-dose of prednisolone after experiencing several relapses. A high CsA trough level (between 147 and 225 ng/mL) over a period of only 5 months was effective in improving the vertebral compression fractures, alleviating the epidural lipomatosis by enabling the discontinuation of prednisolone treatment. Thus, high trough levels of CsA over a short period of time may enable prednisolone to be discontinued in cases of steroid-dependent NS without causing any clinical, histological, serum and/or urinary CsA-related adverse effects.
引用
收藏
页码:414 / 417
页数:4
相关论文
共 50 条
  • [31] Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome
    Kawasaki, Y
    Suzuki, J
    Takahashi, A
    Isome, M
    Nozawa, R
    Suzuki, H
    PEDIATRIC NEPHROLOGY, 2005, 20 (01) : 96 - 98
  • [32] Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome
    Cyrielle Parmentier
    Jean-Daniel Delbet
    Stéphane Decramer
    Olivia Boyer
    Julien Hogan
    Tim Ulinski
    Pediatric Nephrology, 2020, 35 : 455 - 462
  • [33] Rituximab therapy for steroid-dependent minimal change nephrotic syndrome
    Rodney D. Gilbert
    Eleanor Hulse
    Susan Rigden
    Pediatric Nephrology, 2006, 21 : 1698 - 1700
  • [34] A pharmacokinetic study of Neoral in childhood steroid-dependent nephrotic syndrome
    P. Niaudet
    Olivier Reigneau
    Henri Humbert
    Pediatric Nephrology, 2001, 16 : 154 - 155
  • [35] Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome
    K. Al-Saran
    K. Mirza
    G. Al-Ghanam
    M. Abdelkarim
    Pediatric Nephrology, 2006, 21 : 201 - 205
  • [36] Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndrome
    Shori Takahashi
    Naohiro Wada
    Hitohiko Murakami
    Satoshi Funaki
    Tetsuji Inagaki
    Kensuke Harada
    Michio Nagata
    Pediatric Nephrology, 2007, 22 : 232 - 236
  • [37] Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome
    Al-Saran, K
    Mirza, K
    Al-Ghanam, G
    Abdelkarim, M
    PEDIATRIC NEPHROLOGY, 2006, 21 (02) : 201 - 205
  • [38] Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome
    Yukihiko Kawasaki
    Junzo Suzuki
    Ai Takahashi
    Masato Isome
    Ruriko Nozawa
    Hitoshi Suzuki
    Pediatric Nephrology, 2005, 20 : 96 - 98
  • [39] Ischemic colitis as a complication in a patient with steroid-dependent nephrotic syndrome
    Yanagisawa, Atsuhiro
    Namai, Yoshiyuki
    Sekine, Takashi
    Igarashi, Takashi
    PEDIATRIC NEPHROLOGY, 2008, 23 (04) : 655 - 657
  • [40] Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndrome
    Takahashi, Shori
    Wada, Naohiro
    Murakami, Hitohiko
    Funaki, Satoshi
    Inagaki, Tetsuji
    Harada, Kensuke
    Nagata, Michio
    PEDIATRIC NEPHROLOGY, 2007, 22 (02) : 232 - 236